LZAGY - Lonza Group Ltd

Other OTC - Other OTC Delayed Price. Currency in USD
26.55
+0.19 (+0.74%)
At close: 3:59PM EST
Stock chart is not supported by your current browser
Previous Close26.35
Open26.48
Bid0.00 x 0
Ask0.00 x 0
Day's Range26.48 - 26.62
52 Week Range17.69 - 29.56
Volume38,066
Avg. Volume14,704
Market Cap18.793B
Beta1.04
PE Ratio (TTM)23.45
EPS (TTM)1.13
Earnings DateN/A
Forward Dividend & Yield0.30 (1.12%)
Ex-Dividend Date2017-04-26
1y Target EstN/A
Trade prices are not sourced from all markets
  • Reuters5 months ago

    Lonza CFO sees in-house growth, not takeovers, to grow drug services

    A dearth of suitable targets may prompt acquisitive Swiss drug ingredients maker Lonza to expand its new drug product services business on its own, not via takeovers, Chief Financial Officer Rodolfo Savitzky told Reuters. Last year, Lonza poached Roche's biologics supply head, Hanns-Christian Mahler, to lead the unit whose "one-stop" services for pharmaceuticals companies include drug formulation development, analysis and quality control. Savitzky acknowledged Mahler's portfolio still lacks "fill-and-finish" activities, among the final steps in the drug manufacturing process for sophisticated biological medicines.

  • 5 Top-Ranked MedTech Growth Stocks for Solid Returns
    Zacks5 months ago

    5 Top-Ranked MedTech Growth Stocks for Solid Returns

    Despite the ongoing turmoil in the MedTech industry, these stocks with high growth potential can be great bets for investors.

  • Forget Abbott, Buy These 4 High-Growth MedTech Stocks Instead
    Zacks5 months ago

    Forget Abbott, Buy These 4 High-Growth MedTech Stocks Instead

    The share price performance of Abbott Laboratories (ABT) has been disappointing over the last three years. Of the prime issues plaguing Abbott, foreign exchange is a major one.

  • Lonza Group AG :LZAGY-US: Earnings Analysis: For the six months ended June 30, 2017 : August 1, 2017
    Capital Cube7 months ago

    Lonza Group AG :LZAGY-US: Earnings Analysis: For the six months ended June 30, 2017 : August 1, 2017

    Categories: Yahoo FinanceGet free summary analysis Lonza Group AG reports financial results for the half-year ended June 30, 2017. We analyze the earnings along side the following peers of Lonza Group AG – Sarepta Therapeutics, Inc. and Amgen Inc. (SRPT-US and AMGN-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 2,359.22 million, ... Read more (Read more...)

  • Lonza Group AG :LZAGY-US: Earnings Analysis: For the six months ended December 31, 2016 : March 6, 2017
    Capital Cube11 months ago

    Lonza Group AG :LZAGY-US: Earnings Analysis: For the six months ended December 31, 2016 : March 6, 2017

    Categories: Yahoo Finance Get free summary analysis Lonza Group AG reports financial results for the half-year ended December 31, 2016. We analyze the earnings along side the following peers of Lonza Group AG – Sarepta Therapeutics, Inc., Amgen Inc. and Merrimack Pharmaceuticals, Inc. (SRPT-US, AMGN-US and MACK-US) that have also reported for this period. Highlights Summary numbers: Revenues ... Read more (Read more...)